Stress BioSciences Proposed Acquisition Associate Cannaworx, Inc. Publicizes December 2020 Launch Date for FDA Registered Immune Booster

SOUTH EASTON, Mass., Dec. 4, 2020 /PRNewswire/ — Stress BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Firm”), a pacesetter within the growth and sale of broadly enabling, pressure-based devices, consumables, and platform know-how options to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and meals & beverage industries, in the present day introduced that its proposed acquisition companion Cannaworx, Inc. has set December 2020 because the business launch date for its patented immune booster complement: ImmunaZin™.  Cannaworx believes that post-launch, this product will likely be one in all only a few OTC (over-the-counter), FDA registered, hemp seed oil-enhanced dietary supplements with an immune booster declare. 

The immune system’s position is to maintain us wholesome by defending towards invaders (e.g., micro organism and viruses). It’s due to this fact vital to maintain our immune programs as robust and efficient as doable. Wholesome residing is the principle technique advisable  to attain this purpose. One other technique is to enhance wholesome residing with highly effective, top quality immune boosters, which have lately grow to be very talked-about, e.g., the worldwide immune booster market is estimated to exceed $25B by 2025 and the market has been spurred additional by the on-going COVID-19 pandemic.

Dr. Bobby Ghalili, co-founder of Cannaworx, mentioned: “The energetic ingredient in ImmunaZin is a patented, proprietary mix of 44 amino acid fragments derived from the enzyme pepsin. ImmunaZin works by growing the variety of T helper cells within the human physique. T helper cells allow cells referred to as macrophages to kill and devour micro organism, viruses, and different invaders. This makes ImmunoZin strikingly completely different from most different immune boosters available on the market in the present day, as it’s a novel and potent T cell stimulator, enabling the immune system to aggressively defend towards invasions of disease-causing pathogens.”

Dr. Ghalili continued: “To additional improve ImmunaZin’s immune boosting impact, we added hemp seed oil (no THC) to our patented formulation. Hemp seed oil is wealthy in important fatty acids (e.g., omega-6 and omega-3) and antioxidants that will assist struggle irritation, most cancers, diabetes, and coronary heart illness. Omega-Three can also be thought to have a constructive influence on the bowel microbiome as a prebiotic, offering additional assist to the immune system. The manufacturing means of the patented 44 amino acid fragment formulation is very proprietary, protected, and could be practically inconceivable to mimic.”

Mr. Jim Morrison, President of Cannaworx, commented: “We’ve been getting ready for the upcoming December 2020 business launch of ImmunaZin for a lot of months.  We’ve constructed a list of practically 20,000 market-ready packages of product and have the supplies readily available to organize and ship many hundreds extra. We’ve developed a powerful digital advertising and marketing marketing campaign and have readied our inner 5 Leaf Labs gross sales and distribution community (introduced on Could 19, 2020), We count on to considerably add to our inner capabilities by shortly bringing on a number of “wholesale to retail” and “multi-level-marketing” U.S. and worldwide advertising and marketing, gross sales, and distribution companions. We anticipate that our efforts will lead to measurable income earlier than the top of 2020, and substantial development in 2021.”  For added info on ImmunaZin, please go to www.immunazin.com.

Mr. Richard T. Schumacher, President and CEO of Stress BioSciences, added: “Our staff is happy to be becoming a member of an organization bringing such an vital and helpful product to market, significantly contemplating its potential position within the struggle towards the novel coronavirus and different disease-causing pathogens.  We additionally look ahead to bringing our proprietary Extremely-Shear Know-how™ (UST™) platform for the processing of top quality nanoemulsions with vanishingly low and managed droplet sizes, to bear on the rising compendium of Cannaworx private care merchandise rolling out in late 2020 and all through all of 2021.”

The Letter of Intent between Stress BioSciences, Inc. and Cannaworx, Inc. is topic to sure closing situations, together with completion of all due diligence and acquisition financing.

About Cannaworx, Inc.

Cannaworx, a privately held development-stage firm, has developed an in depth portfolio of shopper merchandise, which embrace FDA-registered, patented/patent-pending various product strains. These merchandise capitalize on disruptive supply programs within the areas of ache reduction, prescription drugs, skincare, nutraceuticals, and agriculture/veterinary merchandise.

About Stress BioSciences, Inc.

Stress BioSciences, Inc. (OTCQB: PBIO) is a pacesetter within the growth and sale of revolutionary, broadly enabling, pressure-based options for the worldwide life sciences and different industries. Our merchandise are based mostly on the distinctive properties of each fixed (i.e., static) and alternating (i.e., strain biking know-how, or PCT) hydrostatic strain. PCT is a patented enabling know-how platform that makes use of alternating cycles of hydrostatic strain between ambient and ultra-high ranges to soundly and reproducibly management bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our main focus is within the growth of PCT-based merchandise for biomarker and goal discovery, drug design and growth, biotherapeutics characterization and high quality management, soil & plant biology, forensics, and counter-bioterror functions. Moreover, main new market alternatives have emerged in using our pressure-based applied sciences within the following areas: (1) using our lately acquired, patented know-how from BaroFold, Inc. (the “BaroFold” know-how) to permit entry into the bio-pharma contract companies sector, and (2) using our recently-patented, scalable, high-efficiency, pressure-based Extremely Shear Know-how (“UST”) platform to (i) create secure nanoemulsions of in any other case immiscible fluids (e.g., oils and water) and to (ii) put together increased high quality, homogenized, prolonged shelf-life or room temperature secure low-acid liquid meals that can not be successfully preserved utilizing present non-thermal applied sciences.

Ahead Trying Statements

This press launch accommodates forward-looking statements. These statements relate to future occasions or our future monetary efficiency and contain recognized and unknown dangers, uncertainties and different components that will trigger our or our trade’s precise outcomes, ranges of exercise, efficiency or achievements to be materially completely different from any future outcomes, ranges of exercise, efficiency or achievements expressed, implied or inferred by these forward-looking statements. In some instances, you’ll be able to establish forward-looking statements by terminology similar to “might,” “will,” “ought to,” “might,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” estimates,” “predicts,” “tasks,” “potential” or “proceed” or the destructive of such phrases and different comparable terminology. These statements are solely predictions based mostly on our present expectations and projections about future occasions. You shouldn’t place undue reliance on these statements. In evaluating these statements, it is best to particularly contemplate varied components. Precise occasions or outcomes might differ materially. These and different components might trigger our precise outcomes to vary materially from any forward-looking assertion. These dangers, uncertainties, and different components embrace, however should not restricted to, the dangers and uncertainties mentioned beneath the heading “Threat Components” within the Firm’s Annual Report on Type 10-Ok for the yr ended December 31, 2019, and different experiences filed by the Firm on occasion with the SEC. The Firm undertakes no obligation to replace any of the knowledge included on this launch, besides as in any other case required by regulation.

For extra info about PBI and this press launch, please click on on the following web site hyperlink:http://www.pressurebiosciences.com 

Please go to us on Fb, LinkedIn, and Twitter.

Press Contacts:Richard T. SchumacherPresident & CEO of PBIO(508) 230-1828 (T)

Jim MorrisonPresident of Cannaworx(508) 230-1829 (F)

 

View unique content material:http://www.prnewswire.com/news-releases/pressure-biosciences-proposed-acquisition-partner-cannaworx-inc-announces-december-2020-launch-date-for-fda-registered-immune-booster-301186437.html

SOURCE Stress BioSciences, Inc.

Similar Articles

Comments

Most Popular

17 Kids Who Were Confused About Why Their Actions Made Their Parents Laugh So Hard

https://www.buzzfeed.com/asiawmclain/kids-who-accidentally-made-their-parents-laugh

REvil ransomware is back in full attack mode and leaking data – BleepingComputer

https://www.bleepingcomputer.com/news/security/revil-ransomware-is-back-in-full-attack-mode-and-leaking-data/

A West Virginia city is taking a Tesla patrol car for a test drive – CNN

https://www.cnn.com/2021/09/11/us/tesla-police-car-west-virginia-trnd/index.html